Even Utah Is Falling in Love with Psychedelics
Nobody ever thinks of ultra-conservative Utah as a liberal stronghold. But one company there has already joined companies in California and Arizona in administering psychedelic treatments as a novel solution to depression. And that could mean the legal psychedelics market is poised to explode.
Here's how you could get in on the ground floor
Andrew B. Mccray, insider at AMERISAFE

Andrew B. Mccray Insider Information

EVP of AMERISAFE
Andrew B. McCray serves as Executive Vice President, Chief Underwriting Officer of the Company. Prior to joining the company, he was Senior Director – Global P&C Strategy and Product Innovation for Assurant from January 2017 through April 2019. From 2015-2017, he served as business leader for commercial lines for Utica National Insurance Group and from 2011 to 2015 served as vice president and director of regional underwriting operations for Utica National Insurance Group.

What is Andrew B. Mccray's net worth?

The estimated net worth of Andrew B. Mccray is at least $456,502.93 as of May 21st, 2021. Mccray owns 7,999 shares of AMERISAFE stock worth more than $456,503 as of August 3rd. This net worth evaluation does not reflect any other investments that Mccray may own.

How do I contact Andrew B. Mccray?

The corporate mailing address for Mccray and other AMERISAFE executives is 2301 HIGHWAY 190 WEST, DERIDDER LA, 70634. AMERISAFE can also be reached via phone at 337-463-9052 and via email at [email protected]

Has Andrew B. Mccray been buying or selling shares of AMERISAFE?

Andrew B. Mccray has not been actively trading shares of AMERISAFE over the course of the past ninety days. Most recently, Andrew B. Mccray sold 611 shares of the business's stock in a transaction on Friday, May 21st. The shares were sold at an average price of $65.03, for a transaction totalling $39,733.33. Following the completion of the sale, the executive vice president now directly owns 7,999 shares of the company's stock, valued at $520,174.97.

Who are AMERISAFE's active insiders?

AMERISAFE's insider roster includes G. Frost (CEO), Neal Fuller (CFO), Vincent Gagliano (EVP), Kevin Hogan (EVP), Andrew Mccray (EVP), Kathryn Shirley (CAO), and Sean Traynor (Director).

Are insiders buying or selling shares of AMERISAFE?

In the last year, AMERISAFE insiders bought shares 1 times. They purchased a total of 8,000 shares worth mmore than $508,720.00. In the last year, insiders at the insurance provider sold shares 9 times. They sold a total of 60,901 shares worth mmore than $3,397,916.35. The most recent insider tranaction occured on May, 21st when Andrew B Mccray EVP bought 611 shares worth more than $39,733.33. Insiders at AMERISAFE own 1.7 % of the company.

Information on this page was last updated on 5/21/2021.

Andrew B. Mccray Insider Trading History at AMERISAFE

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/21/2021Sell611$65.03$39,733.337,999View SEC Filing Icon  
See Full Table

Andrew B. Mccray Buying and Selling Activity at AMERISAFE

This chart shows Andrew B Mccray's buying and selling at AMERISAFE by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AMERISAFE Company Overview

AMERISAFE logo
AMERISAFE, Inc., an insurance holding company, underwrites workers' compensation insurance in the United States. Its workers' compensation insurance policies provide benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. The company offers workers' compensation insurance for small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, agriculture, maritime, and oil and gas. The company was incorporated in 1985 and is headquartered in DeRidder, Louisiana.
Read More

Today's Range

Now: $57.07
Low: $56.81
High: $58.00

50 Day Range

MA: $60.18
Low: $55.26
High: $65.53

2 Week Range

Now: $57.07
Low: $53.90
High: $69.47

Volume

101,742 shs

Average Volume

82,954 shs

Market Capitalization

$1.10 billion

P/E Ratio

11.65

Dividend Yield

2.03%

Beta

0.35
Even Utah Is Falling in Love with Psychedelics
Nobody ever thinks of ultra-conservative Utah as a liberal stronghold. But one company there has already joined companies in California and Arizona in administering psychedelic treatments as a novel solution to depression. And that could mean the legal psychedelics market is poised to explode.
Here's how you could get in on the ground floor